natgillin/translations-raw huggingface dataset:
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
U nekliničkim istraživanjima učinci su zabilježeni tek pri razinama ekspozicije koje se smatraju dovoljno većima od maksimalne ekspozicije lijeka u ljudi, što ukazuje na malen značaj za kliničku primjenu.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Učinci u nekliničkim ispitivanjima bili su opaženi samo pri izloženosti koja se smatrala dovoljno većom od najveće izloženosti u ljudi pa su tako od neznatne važnosti za kliničku primjenu.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Učinci u nekliničkim ispitivanjima zabilježeni su samo pri izloženostima koja se smatraju znatno višim od maksimalne izloženosti za ljude, što pokazuje nisku relevantnost za kliničku upotrebu.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Učinci u nekliničkim ispitivanjima zabilježeni su samo pri izloženostima koja se smatraju znatno višim od maksimalneizloženosti za ljude, što pokazuje nisku relevantnost za kliničku upotrebu.
Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to clinical use.
Učinci su uočeni u nekliničkim ispitivanjima samo ako je izloženost znatno premašila maksimalnu dozu izloženosti ljudi, ukazujući na malenu značajnost za kliničku primjenu.
Effects in nonclinical studies with respect to cardiovascular parameters (increased heart rates in dogs), reproductive toxicity (fetotoxic effects), and fertility (slight decreases in conception rate, number of corpora lutea, and pre- and post-implantation losses) were observed only at exposures considered sufficiently in excess of the maximum human exposure indication to be of little relevance to clinical use.
U nekliničkim ispitivanjima, obzirom na kardiovaskularne parametre (povišena frekvencija srca u pasa), reproduktivnu toksičnost (fetotoksični učinci) i plodnost (blago smanjenje stope začeća, broja žutih tijela, te pred- i postimplantacijskih gubitaka) zapaženi su učinci samo pri izloženosti dozama koje se smatraju dovoljno iznad onih maksimalno indiciranih za izloženost ljudi da bi bile od zanemarivog značaja za kliničku primjenu.
Effects in repeated dose studies were observed only at exposures considered sufficiently in excess (>25-, >45-, and >35-fold for mice, rats, and dogs, respectively) of the maximum human exposure of ivacaftor when administered as Orkambi, indicating little relevance to clinical use.
U ispitivanjima ponovljene doze učinci su opaženi samo pri izloženostima koje su se smatrale dovoljno većima (> 25 puta za miševe, > 45 puta za štakore i > 35 puta za pse) od najveće izloženosti u ljudi za ivakaftor kada se primjenjuje kao Orkambi, što ukazuje na njihov mali značaj za kliničku primjenu.
Effects in the eye droopy eyelid (making the eye stay half closed).
Nuspojave na oku spuštena vjeđa (zbog čega je oko poluzatvoreno)
Effects in the eye eye redness.
Nuspojave na oku crvenilo oka.
Effects in the eye inflammation of the eye surface, inflammation of the eyelid, swollen conjunctiva, , increased growth of eyelashes, iris inflammation, eye inflammation, sensitivity to light, reduced vision, tired eyes, eye allergy, eye swelling, increased tear production, eyelid redness, eyelid colour change.
Nuspojave na oku upala površine oka, upala vjeđa, oteklina spojnice, pojačan rast trepavica, upala šarenice, upala oka, osjetljivost na svjetlo, smanjen vid, umor očiju, alergija oka, oticanje oka, pojačano suzenje, crvenilo vjeđa, promjena boje vjeđa.
Effects in the eye: allergic conjunctivitis (eye allergy), eye surface inflammation, eye pain, eye discomfort, blurred or abnormal vision, eye redness
Nuspojave na oku: alergijska upala spojnice (alergija oka), upala površine oka, bol u oku, nelagoda u oku, zamagljen ili poremećen vid, crvenilo oka
Effects in the eye: blurred vision, eye irritation, eye pain, eye discharge, itchy eye, dry eye, abnormal eye sensation, redness of the eye.
Nuspojave na oku: zamagljen vida, iritacija oka, bol u oku, iscjedak iz oka, svrbež oka, suho oko, neuobičajen osjećaj u oku, crvenilo oka.
Effects in the eye: blurred vision, signs and symptoms of eye irritation (e.g burning, stinging, itching, tearing, redness), eye pain.
Nuspojave na oku: zamućen vid, znakovi i simptomi nadražaja oka (npr. žarenje, probadanje, svrbež, suzenje, crvenilo), bol u oku.
Effects in the eye: blurred, reduced, or abnormal vision, corneal disorder, eye surface inflammation with or without surface damage, inflammation or infection of the conjunctiva, eye discharge, sensitivity to light, increased tear production, itchy eye, redness of the eye, eyelid abnormality, itching, redness, swelling, or crusting of the eyelid.
Nuspojave na oku: zamućen, smanjen, ili poremećen vid, poremećaj rožnice, upala površine oka sa ili bez oštećenja površine, upala ili infekcija konjunktive, iscjedak iz oka, osjetljivost na svjetlo, pojačano suzenje, svrbež oka, crvenilo oka, poremećaj vjeđe, svrbež, crvenilo, oticanje vjeđe ili stvaranje krusti na vjeđi.
Effects in the eye: changes in the colour of the iris (coloured part of the eye), eye pain, eye discomfort, dry eye, itchy eye, eye irritation.
Nuspojave na oku: promjena boje šarenice (obojenog dijela oka), bol u oku, nelagoda u oku, suho oko, svrbež oka, nadražaj oka.
Effects in the eye: corneal disorder, abnormal eye sensation, increased tear production, tired eyes, eye irritation, blurred vision, corneal staining, dry eye.
Nuspojave na oku: poremećaj rožnice, poremećen osjet u očima, pojačano suzenje, umor očiju, nadražaj oka, zamućeni vid, obojenje rožnice, suho oko
Effects in the eye: corneal disorder, eye inflammation, iris inflammation, inflammation inside the eye, eye surface inflammation with/out surface damage, sensitivity to light, eye discharge, eyelid inflammation, eyelid redness, swelling around the eye, eyelid itching, reduced vision, blurred vision, increased tear production, infection or inflammation of the conjunctiva (conjunctivitis), abnormal turning outward of the lower eyelid, clouding of the eye, eyelid crusting, growth of eyelashes, discolouration of the eyelashes, tired eyes.
Nuspojave na oku: poremećaj rožnice, upala oka, upala šarenice, upala u unutrašnjosti oka, upala površine oka s/bez oštećenja površine, osjetljivost na svjetlost, iscjedak iz oka, upala vjeđa, crvenilo vjeđa, oticanje područja oko oka, svrbež vjeđe, oslabljeni vid, zamagljen vid, pojačano stvaranje suza, infekcija ili upala konjunktive (konjunktivitis), neuobičajeno okretanje donje vjeđe prema van, zamagljenje oka, stvaranje krusta na vjeđi, rast trepavica, promjena boje trepavica, zamor oka.
Effects in the eye: corneal disorder, eye inflammation, perception of flashing light, eye surface inflammation with/our surface damage, eyelid inflammation, eye swelling, inflammation or infection of the conjunctiva, halo vision, decrease eye sensation, pigmentation inside the eye, cataract, eyelid crusting, tired eyes, increase in pupil size, abnormal turning outward of the lower eyelid, loss of eyelashes, eye viral infection
Nuspojave na oku: poremećaj rožnice, upala oka, percepcija treperećeg svjetla, upala površine oka sa/bez oštećenja površine, upala vjeđe, oticanje oka, upala ili infekcija konjunktive, pojava svjetlećih krugova oko izvora svjetla, smanjeni osjet oka, pigmentacija u unutrašnjosti oka, siva mrena, stvaranje krusta na vjeđema, osjećaj umornih očiju, povećanje veličine zjenica, abnormalno okretanje donje vjeđe prema van, gubitak trepavica, virusna infekcija oka
Effects in the eye: corneal erosion (damage to the front layer of the eyeball), inflammation inside the eye, sensitivity to light, abnormal sensation in the eyes, eye discharge, dry eye, tired eyes, crusting of the eyelid.
Nuspojave na oku: erozija rožnice (oštećenje prednjeg sloja očne jabučice), upala u unutrašnjosti oka, osjetljivost na svjetlost, nenormalan osjećaj u očima, iscjedak iz oka, suho oko, umor očiju, stvaranje krusta na vjeđi.
Effects in the eye: corneal swelling, double or reduced vision, abnormal vision, decreased eye sensation, swelling around the eye, increased pressure in eye, damage to the optic nerve.
Nuspojave na oku: oticanje rožnice, dvostruki ili oslabljeni vid, abnormalan vid, smanjena osjetljivost oka, oticanje oko oka, povišeni tlak u oku, oštećenje vidnog živca.
Effects in the eye: damage of the surface of the eye such as thinning or perforation, impaired healing of the eye, eye surface scar, clouding, reduced vision, eye swelling, blurred vision.
Nuspojave na oku: oštećenje površine oka kao što je stanjivanje ili perforacija, usporeno zacjeljivanje oka, ožiljak na površini oka, zamagljenje, smanjeni vid, iritacija oka, oticanje oka, zamagljen vid.
Effects in the eye: damage on the surface of the eye such as thinning or perforation, impaired healing of the eye, eye surface scar, clouding, reduced vision, eye swelling, blurred vision.
Nuspojave na oku: oštećenje površine oka kao što je stanjivanje ili perforacija, usporeno zacjeljivanje oka, ožiljak na površini oka, zamagljenje, smanjeni vid, iritacija oka, oticanje oka, zamagljen vid.
Effects in the eye: decreased growth of eyelashes
Nuspojave na oku: smanjeni rast trepavica
Effects in the eye: decreased pupil size
Nuspojave na oku: suženje zjenice
Effects in the eye: disturbance of vision, damage to the optic nerve, increased pressure in eye, deposits on the eye surface, corneal disorder, decreased eye sensation, inflammation or infection of the conjunctiva, abnormal, double or reduced vision, increased pigmentation of the eye, growth on surface of eye, increased tear production, eye swelling, sensitivity to light, decreased growth or number of eyelashes, drooping of the upper eyelids (making the eye stay half closed), inflammation of the eyelid and eye lid glands, inflammation in the cornea and detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity.
Nuspojave na oku: poremećaj vida, oštećenje vidnog živca, povišeni tlak u oku, depoziti (talozi) na površini oka, poremećaj rožnice, smanjena osjetljivost oka, upala ili infekcija očne spojnice, nenormalan, dvostruki ili oslabljeni vid, pojačana pigmentacija oka, izraslina na površini oka, pojačano stvaranje suza, oticanje oka, osjetljivost na svjetlo, sporiji rast ili smanjeni broj trepavica, spuštenost gornjih vjeđa (poluzatvoreno oko), upala vjeđa i upala žlijezda vjeđa, upala rožnice i odvajanje sloja ispod mrežnice (žilnice) koji sadrži krvne žile nakon filtracijske operacije što može uzrokovati poremećaj vida, smanjena osjetljivost rožnice.
Effects in the eye: eye pain, eye irritation, dry eye, abnormal eye sensation, eye discomfort
Nuspojave na oku: bol u oku, nadražaj oka, suho oko, neugodan osjećaj u oku, nelagoda u oku
Effects in the eye: eye redness
Nuspojave na oku: crvenilo oka
Effects in the eye: eye redness, changes in the colour of the iris (coloured part of the eye)
Nuspojave na oku: crvenilo oka, promjena boje šarenice (obojenog dijela oka)
Effects in the eye: eye surface damage with loss of cells, inflammation of the eyelid, deposits on the eye surface, sensitivity to light, swelling of the eye (affecting the cornea or eyelid), dry eye, eye discharge, watery eye, eyelid redness, abnormal or decreased sensation in eye, tired eye, reduced vision, double vision, product particles in eyes.
Nuspojave na oku: oštećenje površine oka s gubitkom stanica, upala vjeđa, naslage na površini oka, osjetljivost na svjetlo, oticanje oka (učinak na rožnicu ili vjeđu), suho oko, iscjedak iz oka, pojačano suzenje, crvenilo vjeđa, poremećen ili smanjen osjećaj u oku, umorno oko, oslabljeni vid, dvoslike, čestice lijeka u očima.
Effects in the eye: eye surface inflammation with or without loss or damage of cells, foreign body sensation in the eyes, eyelid crusting or drooping.
Nuspojave na oku: upala površine oka s ili bez gubitka ili oštećenja stanica, osjećaj stranoga tijela u očima, stvaranje krusti na vjeđi ili obješenost vjeđa,
Effects in the eye: eye surface inflammation with or without loss or damage of cells, foreign body sensation in the eyes, eyelid crusting or drooping.
Nuspojave na oku: upala površine oka s ili bez gubitka ili oštećenja stanica, osjećaj stranoga tijela u očima, stvaranje krusti na vjeđi ili obješenost vjeđa.
Effects in the eye: eyelid abnormality, visual disturbance, corneal disorder, eye allergy, decreased growth or number of eyelashes.
Nuspojave na oku: poremećaj vjeđa, smetnje vida, poremećaj rožnice, alergija oka, smanjen rast ili broj trepavica
Effects in the eye: inflammation inside the eye, eye pain, eye surface inflammation with/out surface damage, eye discomfort, eye discharge, sensitivity to light, blurred or abnormal vision, dry eye, itchy eye, increased tear production, eyelid redness, swelling of the eyelid; discolouration of the eyelashes, growth of eyelashes, skin darkening or discolouration around the eye(s)
Nuspojave na oku: upala unutrašnjosti oka, bol u oku, upala površine oka sa/bez oštećenja površine, nelagoda u oku, iscjedak iz oka, osjetljivost na svjetlo, zamućen ili abnormalan vid, suho oko, svrbež oka, pojačano suzenje, crvenilo vjeđa, oticanje vjeđa, promjena boje trepavica, rast trepavica, tamnjenje kože ili promjena boje oko oka (očiju).
Effects in the eye: inflammation inside the eye, eye surface inflammation with/out surface damage, inflammation of the eyelids, inflammation of the conjunctiva, eye pain, sensitivity to light, blurred or abnormal vision, swelling or crusting of eyelids, eye discharge, darkening of skin around the eye(s), growth and change in the texture of the eyelashes
Nuspojave na oku: upala unutrašnjosti oka, upala površine oka sa/bez oštećenja površine, upala vjeđa, upala konjunktive, bol u oku, osjetljivost na svjetlo, zamagljen ili poremećen vid, oteklina ili stvaranje krusta vjeđa, iscjedak iz oka, tamnjenje kože oko oka (očiju), rast i promjena u teksturi trepavica
Effects in the eye: inflammation of the back of the eye, eyes appear more inset
Nuspojave na oku: upala stražnjeg dijela oka, izgled upalih očiju.
Effects in the eye: inflammation of the eyelid, inflammation in the cornea, detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity, corneal erosion (damage to the front layer of the eyeball), double vision, changes in the colour of the iris.
Nuspojave na oku: upala vjeđa, upala rožnice, odvajanje sloja ispod mrežnice (žilnice) koji sadrži krvne žile nakon filtracijske operacije što može uzrokovati poremećaj vida, smanjena osjetljivost rožnice, erozija rožnice (oštećenje prednjeg sloja očne jabučice), dvoslike, promjene u boji šarenice.
Effects in the eye: iris inflammation, eye pain, eye discomfort, dry eye, eyelid swelling, eye irritation, itchy eye, eye discharge, allergic conjunctivitis (eye allergy), increased tear production, deposits on the eye surface, fluid or swelling at the back of the eye, eye redness.
Nuspojave na oku: upala šarenice, bol u oku, nelagoda u oku, suho oko, oticanje vjeđa, iritacija oka, svrbež oka, iscjedak iz oka, alergijski konjunktivitis (alergija oka), pojačano stvaranje suza, depoziti na površini oka, tekućina ili oticanje u stražnjem dijelu oka, crvenilo oka.
Effects in the eye: perception of flashing lights, eczema of the eyelids, eye swelling, halo vision, decreased eye sensation, inflammation of the glands of the eyelids, pigmentation inside the eye, increase in pupil size, change in the texture of the eyelashes.
Nuspojave na oku: percepcija treperećeg svjetla, ekcem vjeđa, oticanje oka, pojava obojenih ili svjetlećih krugova oko izvora svjetlosti, smanjeni osjet oka, upala žlijezda na vjeđama, pigmentacija u unutrašnjosti oka, povećanje veličine zjenice, promjena u teksturi trepavica.
Effects in the eye: sensitivity to light, inflammation or infection of the conjunctiva, eye swelling, eyelid itching, redness or swelling, growth on surface of eye, increased pigmentation of the eye, tired eyes, eyelid crusting, or increased tear production.
Nuspojave na oku: osjetljivost na svjetlo, upala ili infekcija spojnice, oticanje oka, svrbež vjeđa, crvenilo ili oticanje, naslage na površini oka, pojačana pigmentacija oka, umorne oči, krustanje vjeđa ili pojačano stvaranje suza.
effects including
uključujući
effects including
uključujući konstipaciju
effects is recommended
indinavira preporučuje se
Effects noted in other studies included inhibition of human ether-à-go-go related gene (hERG) current and prolongation of QTc interval in dogs.
Učinci zabilježeni u drugim ispitivanjima obuhvaćaju inhibiciju hERG kanala (engl. human ether-a-go-go related gene) i produljenje QTc-intervala u pasa.
Effects observed in repeat-dose toxicity studies were mainly due to the exaggerated pharmacodynamic activity of rivaroxaban.
Učinci uočeni u ispitivanjima toksičnosti ponovljene doze uglavnom su bili rezultat povećane farmakodinamičke aktivnosti rivaroksabana.
Effects observed in repeat-dose toxicity studies were mainly due to the exaggerated pharmacodynamic activity of rivaroxaban.
Učinci uočeni u ispitivanju toksičnosti ponovljene doze uglavnom su bili rezultat povećane farmakodinamičke aktivnosti rivaroksabana.
Effects observed in repeat-dose toxicity studies were mainly due to the exaggerated pharmacodynamic activity of rivaroxaban.
Učinci uočeni u ispitivanju toksičnosti ponovljenih doza uglavnom su bili rezultat povećane farmakodinamičke aktivnosti rivaroksabana.
Effects observed in the repeat-dose toxicity studies were due to the exaggerated pharmacodynamic effect of dabigatran.
Učinci primjećeni u ispitivanjima toksičnosti ponovljenih doza bili su uzrokovani pretjeranim farmakodinamičkim učinkom dabigatrana.
Effects of aclidinium in nonclinical studies with respect to reproductive toxicity (fetotoxic effects) and fertility (slight decreases in conception rate, number of corpora lutea, and pre- and post-implantation losses) were observed only at exposures considered sufficiently in excess of the maximum human exposure indication to be of little relevance to clinical use.
U nekliničkim ispitivanjima zapaženi su učinci aklidinija s obzirom na reproduktivnu toksičnost (fetotoksični učinci) i plodnost (blago smanjenje stope začeća, broja žutih tijela, te pred- i postimplantacijskih gubitaka) samo pri izloženostima koje su bile znatno veće od maksimalnih izloženosti u ljudi, što ukazuje na njihov mali značaj za kliničku primjenu.
Effects of Age:
Učinak dobi:
Effects of amlodipine on other medicinal products
Učinci amlodipina na druge lijekove
Effects of apremilast on pregnancy included embryofetal loss in mice and monkeys, and reduced fetal weights and delayed ossification in mice at doses higher than the currently recommended highest human dose.
Učinci apremilasta na trudnoću uključivali su embrioefetalni gubitak u miševa i majmuna, smanjenje fetalne težine te odgođenu osifikaciju u miševa pri dozama višim od trenutačno preporučene najviše doze za ljude.
Effects of bexarotene on other substances: there are indications that bexarotene may induce CYP3A4.
Učinci beksarotena na druge tvari: Postoje pokazatelji da beksaroten može inducirati CYP3A4.
Effects of brivaracetam on other medicinal products
Učinci brivaracetama na druge lijekove
Effects of canagliflozin on other medicinal products Digoxin
Učinci kanagliflozina na druge lijekove Digoksin
Effects of dabrafenib on other substances
Učinci dabrafeniba na druge tvari
Effects of darifenacin on other medicinal products
Učinci darifenacina na druge lijekove
Effects of dexamethasone on other medicinal products
Učinci deksametazona na druge lijekove
Effects of Efient on other medicinal products
Učinci lijeka Efient na druge lijekove
Effects of eltrombopag on other medicinal products
Učinci eltrombopaga na druge lijekove
Effects of esomeprazole on the pharmacokinetics of other medicinal products
Učinci esomeprazola na farmakokinetiku drugih lijekova
Effects of food on oral absorption
Utjecaj hrane na apsorpciju nakon peroralne primjene
Effects of food on oral absorption
Utjecaji hrane na apsorpciju nakon peroralne primjene
Effects of gender
Učinci spola
Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5 year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography.
Učinak inzulina glargina (primijenjenog jedanput dnevno) na dijabetičku retinopatiju ocijenjen je u 5- godišnjem otvorenom kliničkom ispitivanju kontroliranom NPH inzulinom (NPH primijenjen dvaput na dan) na 1024 bolesnika sa šećernom bolešću tipa 2, u kojih je progresija retinopatije za više od 3 stupnja na ljestvici ETDRS (Early Treatment Diabetic Retinopathy Study) bila ispitana fotografiranjem fundusa.
Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5 year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography.
Učinci inzulina glargina (jedanput na dan) na dijabetičku retinopatiju ocijenjeni su u 5-godišnjem otvorenom kliničkom ispitivanju kontroliranom NPH inzulinom (NPH se primjenjivao dvaput na dan) u 1024 bolesnika sa šećernom bolešću tipa 2, u kojih je progresija retinopatije za 3 stupnja ili više na ljestvici ETDRS (Early Treatment Diabetic Retinopathy Study) bila ispitana fotografiranjem fundusa.
Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5-year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography.
Učinak inzulina glargina (primijenjenog jedanput dnevno) na dijabetičku retinopatiju ocijenjen je u 5- godišnjem otvorenom kliničkom ispitivanju kontroliranom NPH inzulinom (NPH primijenjen dvaput na dan) na 1024 bolesnika sa šećernom bolešću tipa 2, u kojih je progresija retinopatije za više od 3 stupnja na ljestvici ETDRS (Early Treatment Diabetic Retinopathy Study) bila ispitana fotografiranjem fundusa.
Effects of Ketoconazole HRA on the metabolism of the other medicinal products
Učinci Ketoconazolea HRA na metabolizam drugih lijekova
Effects of mercaptopurine on other medicinal products
Utjecaj merkaptopurina na druge lijekove
Effects of other agents on the pharmacokinetics of brivaracetam
Učinci drugih lijekova na farmakokinetiku brivaracetama
Effects of other drugs on trametinib: In vivo and in vitro data suggest that the pharmacokinetics of trametinib are unlikely to be affected by other medicinal products.
Učinci drugih lijekova na trametinib: In vitro i in vivo podaci pokazuju da nije vjerojatno da bi drugi lijekovi mogli utjecati na farmakokinetiku trametiniba.
Effects of other medicinal products on cobimetinib
Učinci drugih lijekova na kobimetinib
Effects of other medicinal products on darifenacin
Učinci drugih lijekova na darifenacin
Effects of other medicinal products on dexamethasone
Učinci drugih lijekova na deksametazon
Effects of other medicinal products on Efient
Učinci drugih lijekova na Efient
Effects of other medicinal products on intravenous sildenafil
Učinci drugih lijekova na sildenafil primijenjen intravenski
Effects of other medicinal products on Lojuxta and other forms of interaction
Učinci drugih lijekova na Lojuxtu i drugi oblici interakcija
Effects of other medicinal products on mercaptopurine
Utjecaj drugih lijekova na merkaptopurin